Article highlights & insights
Mitotic entry is a tightly regulated process controlled by CDK1-Cyclin B1. Its activity is negatively regulated by the WEE family kinases, WEE1, WEE2 and PKMYT1, to prevent premature mitotic entry. While WEE1 has an established role in regulating CDK2 during S-phase, the full scope of PKMYT1’s roles in the cell cycle is surprisingly unexplored. Here, we show that PKMYT1 activity increases during anaphase and we reveal a novel mitotic function for PKMYT1 that is distinct from its family member WEE1. Chemical inhibition of PKMYT1 induces premature anaphase, leading to chromosome segregation errors. These errors, including chromatin bridges and micronuclei, consequently activate the cGAS–STING pathway. We further demonstrate that PKMYT1 contributes to maintaining spindle assembly checkpoint integrity, as its inhibition promotes mitotic slippage in the presence of anti-microtubule drugs. Our findings reveal that PKMYT1 provides an additional regulatory mechanism, acting alongside Cyclin B1 degradation, to control CDK1-Cyclin B1 activity and ensure the fidelity of the metaphase-to-anaphase transition.
Mitotic entry is a tightly regulated process controlled by CDK1-Cyclin B1. Its activity is negatively regulated by the WEE family kinases, WEE1, WEE2 and PKMYT1, to prevent premature mitotic entry. While WEE1 has an established role in regulating CDK2 during S-phase, the full scope of PKMYT1’s roles in the cell cycle is surprisingly unexplored. Here, we show that PKMYT1 activity increases during anaphase and we reveal a novel mitotic function for PKMYT1 that is distinct from its family member WEE1. Chemical inhibition of PKMYT1 induces premature anaphase, leading to chromosome segregation errors. These errors, including chromatin bridges and micronuclei, consequently activate the cGAS–STING pathway. We further demonstrate that PKMYT1 contributes to maintaining spindle assembly checkpoint integrity, as its inhibition promotes mitotic slippage in the presence of anti-microtubule drugs. Our findings reveal that PKMYT1 provides an additional regulatory mechanism, acting alongside Cyclin B1 degradation, to control CDK1-Cyclin B1 activity and ensure the fidelity of the metaphase-to-anaphase transition.
Institute Authors
Groups
Group leader
https://www.cell.com/cell/fulltext/S0092-8674(26)00522-2
Plasma signals of lung tumor promotion for molecular cancer prevention
25 June 2026
Institute Authors (1)
William Hill
Research Group
Cancer Origins
25 June 2026
https://link.springer.com/article/10.1038/s44319-026-00809-1
PKMYT1 has an important role in the timing and fidelity of chromosome segregation
5 June 2026
Institute Authors (5)
Asma Belbelazi, Charlie Greenaway-Wells, Zoe Edwards, Keren Dawson, Iain Hagan
Research Group
Cell Division
5 June 2026
https://www.nature.com/articles/s42255-026-01514-y
Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion
27 April 2026
Institute Authors (4)
Amaya Virós, Noah Palombo, Charlotte Russell, Claus Jørgensen
Research Group
Skin Cancer & Ageing
27 April 2026
https://www.cell.com/cancer-cell/fulltext/S1535-6108(26)00114-5
Immunometabolic gatekeeping: How tissue metabolism conditions tumor immunity
13 April 2026
Institute Authors (1)
Samra Turajlić
Research Group
Cancer Dynamics
13 April 2026
https://www.nature.com/articles/s41467-026-69964-2
Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune response
25 February 2026
Institute Authors (1)
Sylvain Delaunay
Research Group
RNA Dynamics in Cancer
25 February 2026
https://doi.org/10.1038/s44161-025-00740-z
Single-cell profiling reveals three endothelial-to-hematopoietic transitions with divergent isoform expression landscapes
11 November 2025
Institute Authors (6)
Robert Sellers, John Weightman, Wolfgang Breitwieser, Natalia Moncaut, Michael Lie-a-ling, Georges Lacaud
Labs & Facilities
Computational Biology Support, Molecular Biology, Genome Editing and Mouse Models
Research Group
Stem Cell Biology
11 November 2025



